🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.8399
-0.0855 (-9.24%)
At close: Nov 20, 2026, 4:00 PM EST
0.8700
+0.0301 (3.58%)
After-hours: Nov 20, 2026, 7:51 PM EST

Palisade Bio Statistics

Total Valuation

Palisade Bio has a market cap or net worth of $150.58 million. The enterprise value is $36.96 million.

Market Cap150.58M
Enterprise Value 36.96M

Important Dates

The last earnings date was Tuesday, November 10, 2026, after market close.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

Palisade Bio has 179.28 million shares outstanding. The number of shares has increased by 4,252.89% in one year.

Current Share Class 179.28M
Shares Outstanding 179.28M
Shares Change (YoY) +4,252.89%
Shares Change (QoQ) +0.31%
Owned by Insiders (%) 2.20%
Owned by Institutions (%) 80.42%
Float 138.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 301.15
Forward PS n/a
PB Ratio 1.30
P/TBV Ratio 1.34
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 73.92
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 20.16, with zero debt.

Current Ratio 20.16
Quick Ratio 19.50
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -16,042.33

Financial Efficiency

Return on equity (ROE) is -75.56% and return on invested capital (ROIC) is -51.92%.

Return on Equity (ROE) -75.56%
Return on Assets (ROA) -69.63%
Return on Invested Capital (ROIC) -51.92%
Return on Capital Employed (ROCE) -42.70%
Weighted Average Cost of Capital (WACC) 13.14%
Revenue Per Employee $35,714
Profits Per Employee -$3.12M
Employee Count14
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -61.29% in the last 52 weeks. The beta is 1.62, so Palisade Bio's price volatility has been higher than the market average.

Beta (5Y) 1.62
52-Week Price Change -61.29%
50-Day Moving Average 1.37
200-Day Moving Average 1.81
Relative Strength Index (RSI) 24.56
Average Volume (20 Days) 4,065,281

Short Selling Information

The latest short interest is 29.29 million, so 16.34% of the outstanding shares have been sold short.

Short Interest 29.29M
Short Previous Month 31.75M
Short % of Shares Out 16.34%
Short % of Float 21.14%
Short Ratio (days to cover) 9.80

Income Statement

In the last 12 months, Palisade Bio had revenue of $500,000 and -$43.70 million in losses. Loss per share was -$0.21.

Revenue500,000
Gross Profit 500,000
Operating Income -48.13M
Pretax Income -43.70M
Net Income -43.70M
EBITDA -48.12M
EBIT -48.13M
Loss Per Share -$0.21
Full Income Statement

Balance Sheet

The company has $113.61 million in cash and no debt, with a net cash position of $113.61 million or $0.63 per share.

Cash & Cash Equivalents 113.61M
Total Debt n/a
Net Cash 113.61M
Net Cash Per Share $0.63
Equity (Book Value) 112.44M
Book Value Per Share 0.64
Working Capital 111.65M
Full Balance Sheet

Cash Flow

Operating Cash Flow -26.40M
Capital Expenditures n/a
Depreciation & Amortization 2,250
Net Borrowing -211,000
Free Cash Flow -26.40M
FCF Per Share -$0.15
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -9,625.40%
Pretax Margin -8,739.20%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Palisade Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -4,252.89%
Shareholder Yield -4,252.89%
Earnings Yield -24.81%
FCF Yield -17.53%

Analyst Forecast

The average price target for Palisade Bio is $8.70, which is 935.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.70
Price Target Difference 935.84%
Analyst Consensus Strong Buy
Analyst Count 10
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on April 8, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date Apr 8, 2024
Split Type Reverse
Split Ratio 1:15

Scores

Palisade Bio has an Altman Z-Score of 27.34 and a Piotroski F-Score of 2.

Altman Z-Score 27.34
Piotroski F-Score 2